Back to search
Colorectal Liver Metastasis (CRLM)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Colorectal Liver Metastasis (CRLM) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Colorectal Liver Metastasis (CRLM) trials you may qualify forThis is a prospective, randomized controlled, single-center phase II clinical study. It aims to compare the efficacy of AK104 plus radiotherapy combined with st…
This multicenter, retrospective study aims to develop and validate a multimodal deep learning model for predicting the risk of metachronous liver metastasis in…
Colorectal cancer is the third most common cancer worldwide and the fourth most common cause of cancer-related death. Survival is primarily determined by stage…
Colorectal cancer is the third most common malignancy worldwide, and prognosis largely depends on how effectively metastatic disease is managed. The liver is th…
The goal of this observational study is to investigate whether circulating tumor-derived DNA (ctDNA) can be reliably detected and analyzed in blood obtained thr…
This study is an interventional open label prospective study that aims to assess both overall and disease-free survival of patients treated with LDLT, partial o…
This is a prospective, single-center, single-arm exploratory clinical study designed to evaluate the efficacy and safety of hepatic arterial infusion of liposom…
For patients with colorectal liver metastases (CRLM) ≤5 cm, Clinical guidelines recommend surgery, but a growing number of studies have shown that thermal ablat…